CIR.L Regulatory News (CIR)

31 May 2017

Circassia Pharmaceuticals plc

Block Listing Application

Circassia Pharmaceuticals plc ("Circassia" or "the Company") today announces that an application (the "Application") has been made to the UK Listing Authority and the London Stock Exchange for a block listing of 1,016,000 ordinary shares of 0.08 pence each in the Company ("Ordinary Shares") to be admitted to trading on the Premium Segment of the London Stock Exchange.

The Application relates to Ordinary Shares to be issued from time to time in order to satisfy the potential exercise of share options granted under employee share schemes:

2007 Unapproved Share Scheme: 516,000 Ordinary Shares

2014 Performance Share Plan Scheme: 500,000 Ordinary Shares

It is expected that admission will become effective on 1 June 2017. When issued, the Ordinary Shares will rank pari passu with the existing ordinary shares of the Company.

As at today, there are 332,244,588 ordinary shares in issue with one voting right per share. The Company does not hold any shares in treasury. The Company will notify on a monthly basis when there are changes to the issued share capital of the Company, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

-Ends-

For further information, please contact:

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary Tel: +44 (0) 1865 405 560